Two Sigma Securities’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Two Sigma Securities’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$237	Buy	+20,393	New	+$245	﹤0.01%	1590
2025 Q3	–	Sell	-31,836	Closed	-$748	–	1483
2025 Q2	$748	Buy	31,836 +20,300	+176%	+$445	﹤0.01%	1413
2025 Q1	$125	Buy	+11,536	New	+$302	﹤0.01%	1391
2024 Q2	–	Sell	-14,026	Closed	-$358	–	3068
2024 Q1	$358	Sell	14,026 -11,204	-44%	-$459	﹤0.01%	2873
2023 Q4	$782	Buy	+25,230	New	+$992	﹤0.01%	2932

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's COEPW Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Coeptis Therapeutics Warrants (COEPW) in Q1 2026: 20,393 shares worth $237. The stake represents ﹤0.01% of the portfolio and ranks #1590 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in COEPW as recently as Q2 2025.

Two Sigma Securities first reported a position in COEPW in Q4 2023 and has held it in 5 quarters since. The position peaked at $782 in Q4 2023. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

Two Sigma Securities held 20,393 shares of Coeptis Therapeutics Warrants worth $237 as of Q1 2026.
Coeptis Therapeutics Warrants was a new Two Sigma Securities position in Q1 2026.
Coeptis Therapeutics Warrants made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1590 holding.
Two Sigma Securities first reported a position in Coeptis Therapeutics Warrants in Q4 2023 and has held it in 5 quarters since.
Two Sigma Securities's Coeptis Therapeutics Warrants position peaked at $782 in Q4 2023.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.